Joint Clinical Practice Guideline on Benzodiazepine Tapering¶
American Society of Addiction Medicine. (2025). Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. Journal of General Internal Medicine, 40(12), 2814-2859.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Fading
- Because the underlying structure — install, monitor, taper, release — is identical, the transfer carries not just inspiration but reusable schedule designs and instrumentation.
This sourceclinical guideline formalizing pharmacological weaning — dose reduced in small graduated increments (initial pace ~5–10% of total daily dose every 2–4 weeks) rather than discontinued abruptly, precisely to avoid withdrawal shock; the verified 5–10%/2–4-week figure matches the prime's annotation.
- Because the underlying structure — install, monitor, taper, release — is identical, the transfer carries not just inspiration but reusable schedule designs and instrumentation.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:964809535784 · see in the full table